NCT06279728
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06279728
Title Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Daiichi Sankyo
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Queen's Medical Center Honolulu Hawaii 96813 United States Details
Graves Gilbert Clinic Bowling Green Kentucky 42101 United States Details
Touro Infirmary - LCMC Health New Orleans Louisiana 70115 United States Details
University of Maryland Medical Center Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) Detroit Michigan 48201 United States Details
Henry Ford Health Detroit Michigan 48202 United States Details
Central Care Cancer Center Bolivar Missouri 65613 United States Details
Overlook Medical Center Medical Diagnostic Associates Atlantic Medical Group Summit New Jersey 07901 United States Details
New York Cancer & Blood Specialists New York New York 10028 United States Details
Baptist Cancer Center Memphis Tennessee 38120 United States Details
University of Texas Southwestern Medical Dallas Texas 75390 United States Details
Houston Methodist Hospital Cancer Center Houston Texas 77030 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field